ANTIPROLIFERATIVE COMPOUNDS
The present invention relates to new compounds of general formula (I), wherein the groups R1 to R3, X1, X2, X3 and L1 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof in such a treatment.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
10.06.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to new compounds of general formula (I), wherein the groups R1 to R3, X1, X2, X3 and L1 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof in such a treatment. |
---|---|
AbstractList | The present invention relates to new compounds of general formula (I), wherein the groups R1 to R3, X1, X2, X3 and L1 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof in such a treatment. |
Author | ETTMAYER PETER STEURER STEFFEN MANTOULIDIS ANDREAS |
Author_xml | – fullname: ETTMAYER PETER – fullname: MANTOULIDIS ANDREAS – fullname: STEURER STEFFEN |
BookMark | eNrjYmDJy89L5WSQdvQL8QwI8vfxdHMNcgzxDHNVcPb3DfAP9XMJ5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8d5BRgaGhgYGZsam5iaOxsSpAgDRaiN2 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | KR20110063574A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_KR20110063574A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:56:13 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Korean |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_KR20110063574A3 |
Notes | Application Number: KR20117009679 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110610&DB=EPODOC&CC=KR&NR=20110063574A |
ParticipantIDs | epo_espacenet_KR20110063574A |
PublicationCentury | 2000 |
PublicationDate | 20110610 |
PublicationDateYYYYMMDD | 2011-06-10 |
PublicationDate_xml | – month: 06 year: 2011 text: 20110610 day: 10 |
PublicationDecade | 2010 |
PublicationYear | 2011 |
RelatedCompanies | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
RelatedCompanies_xml | – name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
Score | 2.7728677 |
Snippet | The present invention relates to new compounds of general formula (I), wherein the groups R1 to R3, X1, X2, X3 and L1 are defined as in claim 1, which are... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | ANTIPROLIFERATIVE COMPOUNDS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110610&DB=EPODOC&locale=&CC=KR&NR=20110063574A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsQDWwilJhqa6aUkmSbomiYmpupbAPpuueZqxUWKSsTGwSQ4a7_D1M_MINfGKMI1gYsiB7YUBnxNaDj4cEZijkoH5vQRcXhcgBrFcwGsri_WTMoFC-fZuIbYuaimw4T5g9WSg5uJk6xrg7-LvrObsbOsdpOYXBJEzAB2-ZuLIzMAKOngLdNK-a5gTaF9KAXKl4ibIwBYANC-vRIiBKTtfmIHTGXb3mjADhy90yhvIhOa-YhEGaUe_EM-AIH8fTzdX0NhSmKuCs79vgH-on0uwKIOym2uIs4cu0JZ4uKfivYOQnWQsxsAC7O6nSjAopAG7hknGqRYmlmlpJkkmZkmJluYpRkkpKcYWpklJ5iaSDDL4TJLCLy3NwAUZFTUDFsAyDCwlRaWpssBqtSRJDhwaAPdKd9w |
link.rule.ids | 230,308,780,885,25564,76547 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFetNq6K2akHJLVi7m9chSJsHiXkS09JbyJoERLHFRvz7TtJGe-pt2YHZB8zr250ZgHsZrXDGHgW-YJTxNE1zXsGYjZcKMkoZIeiSV3iH54vWlD7PhXkLPppcmLpO6E9dHBEl6hXlvaz19fIfxNLrv5WrB_aGU4snM1Z1LmvgPjRPQ06fqEYY6IHGaZrqRJwfrWnDqvgaHe_BvlT13K2cp9mkyktZbhsV8xgOQuT3WZ5A633RhY7W9F7rwqG3efLG4Ub6VqfQG_uxHUaBa5tGhS3NjIEWeGEw9fWXM7gzjVizeFwl-TtU4kTbWyLn0MZwP7-AQYGhISO5TJWioIyKLFWkbMSyjMgCYxK9hP4uTle7ybfQsWLPTVzbd3pwtEZIRVTGfWiXX9_5NZrYkt3UN_MLvvJ6zQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTIPROLIFERATIVE+COMPOUNDS&rft.inventor=ETTMAYER+PETER&rft.inventor=MANTOULIDIS+ANDREAS&rft.inventor=STEURER+STEFFEN&rft.date=2011-06-10&rft.externalDBID=A&rft.externalDocID=KR20110063574A |